leadf
logo-loader
Mindset Pharma Inc - Mindset Pharma leading the charge to advance psychedelic medicines to treat mental illness

The company is developing intellectual property in two areas it believes are going to be the...

6 days, 22 hours ago
What brokers say

Maxim Group hikes price target for Mindset Pharma to US$1.50 after the...

Maxim's analysts said: "Mindset is making progress across its families of next-gen psychedelic...

6 days, 23 hours ago
Deep dive

Braxia Scientific is making a scientific case for psychedelic medicine

As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics...

on 08/10/2021
Insight

Mindset Pharma is part of an exciting crop of psychedelics firms that are...

Investors are getting excited about next generation psychedelics that aim to deliver better...

on 07/23/2021
Deep dive

Revive Therapeutics advancing repurposed gout drug to fight coronavirus and...

The company is enrolling patients in a Phase 3 clinical trial to evaluate Bucillamine in...

on 07/20/2021

Mindset Pharma say latest results further validate lead candidate's...

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF, FRA:9DF) (CSE:MSET) (OTCQB:MSSTF) (FRA:9DF) CEO James Lanthier and Chief Scientific Officer Joseph Araujo tell Proactive that its lead candidate MSP-1014 was comparable to psilocybin assessed using a drug discrimination assay. Araujo and Lanthier...

1 day, 1 hour ago